RenovoRx (NASDAQ:RNXT) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen has upgraded RenovoRx (NASDAQ:RNXT) from a "sell" to a "hold" rating, while the overall analyst consensus remains a "Moderate Buy" with an $8.50 average price target. The company reported a narrower-than-expected quarterly loss of $0.05 per share and revenues of $0.91 …